Having identified an “urgent” need for guardrails to keep healthcare AI from veering into an avoidable ditch, the Coalition for Health AI has put together a 24-page guide applicable to numerous groups of stakeholders.

Bhvita Jani, research manager at the healthcare market analysis firm Signify Research, shares noteworthy happenings from the ECR expo floor.

The company is still riding the momentum of its technology being included in the 2021 American College of Cardiology/American Heart Association chest pain guidelines.

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.

A new report from the Joint Commission has laid bare a dramatic increase in sentinel events, up 19% in 2022 compared to the previous year, with the majority happening in hospital settings.

According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.

Most patients who received mechanical ventilation for COVID-19 at a busy European hospital not only survived but also showed no scarring or thickening on lung CT at two years post-discharge.

Radiology makes up the vast majority of FDA-cleared AI algorithms, but with minimal or no reimbursement, hospital administrators may ask whether AI’s value justifies its expense.